Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000463871 | SCV000558867 | likely benign | Fanconi anemia | 2025-01-09 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001292767 | SCV001481413 | uncertain significance | Fanconi anemia complementation group A | 2020-09-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002475905 | SCV002774151 | likely benign | not provided | 2022-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002525658 | SCV003712303 | likely benign | Inborn genetic diseases | 2024-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV002475905 | SCV004224275 | uncertain significance | not provided | 2022-12-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003960075 | SCV004782877 | likely benign | FANCA-related disorder | 2019-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |